FolioLanternBeta
PTCTPtc Therapeutics, Inc.

Glenn Steele Jr.

Director at Ptc Therapeutics, Inc., as of Oct 2, 2026Sold $1.7M of stock in the past 12 months: 100% under a disclosed plan.

Updated Oct 15, 2026 from SEC filings · covers Oct 16, 2025 to Oct 15, 2026
23K
shares held after the latest filing, Ptc Therapeutics, Inc.
Vested shares reported on Forms 3, 4 and 5 only. Not the insider's whole wealth.
24K
shares sold, past 12 months
2
days with sales
$916K
largest single day, Jan 2, 2026
1
company filed for

Share of stake sold at Ptc Therapeutics, Inc. is not shown: most of their shares vested during the period, so a percentage would mislead. Why

Selling by month

Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.

Disclosed planOne dollar scale for every month; the tallest bar is labeled
OctNovDecJan 2026: $916K under a disclosed plan$916KJanFebMarAprMayJunJulAugSep 2026: $782K under a disclosed planSepOct

Pattern

What the filings show, past 12 months. Nothing here rates or predicts.

Roles from filings

Every company we track where this person has filed, newest filing first.

CompanyTitleFirst filingLatest filing
Ptc Therapeutics, Inc. (PTCT)DirectorJun 11, 2015Oct 2, 2026

Recent filings

The last 2 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.

This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.